Mack Gene 4
4 · Gain Therapeutics, Inc. · Filed Aug 12, 2024
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Purchase
Common Stock
2024-08-09$1.01/sh+14,400$14,544→ 14,400 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.98 to $1.07 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.